Therapeutic drug monitoring in anticancer agents: perspectives of Australian medical oncologists

- Flynn, Alexandra, Galettis, Peter, Gurney, Howard, Michael, Michael, Desar, Ingrid, Westerdijk, Kim, Schneider, Jennifer, Martin, Jennifer

Prevalence of Australians exposed to potentially cardiotoxic cancer medicines: a population-based cohort study

- Daniels, Benjamin, Aslam, Maria, van Leeuwen, Marina T., Brown, Martin, Hunt, Lee, Gurney, Howard, Tang, Monica, Pearson, Sallie-Anne, Vajdic, Claire M.

High melphalan exposure is associated with improved overall survival in myeloma patients receiving high dose melphalan and autologous transplantation

- Nath, Christa E., Trotman, Judith, Nivison-Smith, Ian, Zeng, Lihua, Shaw, Peter J., Tiley, Campbell, Presgrave, Peter, Joshua, Douglas, Kerridge, Ian, Kwan, Yiu Lam, Gurney, Howard, McLachlan, Andrew J., Earl, John W.

Population pharmacokinetics of melphalan in patients with multiple myeloma undergoing high dose therapy

- Nath, Christa E., Shaw, Peter J., Presgrave, Peter, Tiley, Campbell, Joshua, Douglas, Earl, John, Trotman, Judith, Zeng, Lihua, Duffull, Stephen B., Hegarty, Gareth, McLachlan, Andrew J., Gurney, Howard, Kerridge, Ian, Kwan, Ylu Lam

Predictors of vinorelbine pharmacokinetics and pharmacodynamics in patients with cancer

- Wong, Mark, Balleine, Rosemary L., Hoskins, Janelle M., Mann, Graham J., Clarke, Christine L., Gurney, Howard, Blair, Elaine Y. L., McLachlan, Andrew J., Ackland, Stephen P., Garg, Madhu B., Evans, Scott, Farlow, David, Collins, Michael, Rivory, Laurent P.